This suggests that abnormal glutamatergic transmission in the striatum may contribute to the pathophysiology of PD (reviewed in [20]) and A2AR-mediated potentiation of glutamatergic function may be a contributing factor (reviewed in [13]). Here, ADORA2A is linked to Parkinson disease.